PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33356742-1	2021	In the current study, chitosan (CS) caged classic liposomes (CLs) and flexible liposomes (FLs) were developed to enhance the oral bioavailability of rivaroxaban (RVX) in the fasted condition.	Rivaroxaban	149-160	citrate synthase	Homo sapiens	32-34	
33356742-1	2021	In the current study, chitosan (CS) caged classic liposomes (CLs) and flexible liposomes (FLs) were developed to enhance the oral bioavailability of rivaroxaban (RVX) in the fasted condition.	Rivaroxaban	162-165	citrate synthase	Homo sapiens	32-34	
33356742-6	2021	The result highlighted the efficacy of the prepared liquid formulation comprising CS coated liposomes in improving the oral bioavailability of RVX regardless of the fed state.	Rivaroxaban	143-146	citrate synthase	Homo sapiens	82-84	
32173474-7	2020	The addition of rivaroxaban to AAA reverted the activity of both citrate synthase and cytochrome C oxidase to similar values to control.	Rivaroxaban	16-27	citrate synthase	Homo sapiens	65-81